These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2548173)

  • 41. Comparison of L-[3H]glutamate, D-[3H]aspartate, DL-[3H]AP5 and [3H]NMDA as ligands for NMDA receptors in crude postsynaptic densities from rat brain.
    Foster AC; Fagg GE
    Eur J Pharmacol; 1987 Jan; 133(3):291-300. PubMed ID: 2881792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites.
    Rothman RB; Reid AA; Monn JA; Jacobson AE; Rice KC
    Mol Pharmacol; 1989 Dec; 36(6):887-96. PubMed ID: 2557536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A radiohistochemical measure of [3H]TCP binding to the activated NMDA-receptor-gated ion channel in rat brain.
    Hosford DA; Bonhaus DW; McNamara JO
    Brain Res; 1990 May; 516(2):192-200. PubMed ID: 1694710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture.
    Halliwell RF; Peters JA; Lambert JJ
    Br J Pharmacol; 1989 Feb; 96(2):480-94. PubMed ID: 2647206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain.
    Murphy DE; Hutchison AJ; Hurt SD; Williams M; Sills MA
    Br J Pharmacol; 1988 Nov; 95(3):932-8. PubMed ID: 2850065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [3H]MK-801 binding sites in neonate rat brain.
    Morin AM; Hattori H; Wasterlain CG; Thomson D
    Brain Res; 1989 May; 487(2):376-9. PubMed ID: 2567199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex.
    Loo PS; Braunwalder AF; Lehmann J; Williams M; Sills MA
    Mol Pharmacol; 1987 Dec; 32(6):820-30. PubMed ID: 2892125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.
    Herberg LJ; Rose IC
    Psychopharmacology (Berl); 1989; 99(1):87-90. PubMed ID: 2550989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats.
    Ormandy GC; Jope RS; Snead OC
    Exp Neurol; 1989 Nov; 106(2):172-80. PubMed ID: 2553470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MK-801 pretreatment enhances N-methyl-D-aspartate-mediated brain injury and increases brain N-methyl-D-aspartate recognition site binding in rats.
    McDonald JW; Silverstein FS; Johnston MV
    Neuroscience; 1990; 38(1):103-13. PubMed ID: 2255390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
    Marrannes R; Willems R; De Prins E; Wauquier A
    Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. (+)-[3H]MK-801 binding sites in postmortem human brain.
    Quarum ML; Parker JD; Keana JF; Weber E
    J Neurochem; 1990 Apr; 54(4):1163-8. PubMed ID: 2156014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of D-3,4-cyclopropylglutamates as N-methyl-D-aspartate receptor agonists.
    Monahan JB; Hood WF; Compton RP; Cordi AA; Snyder JP; Pellicciari R; Natalini B
    Neurosci Lett; 1990 May; 112(2-3):328-32. PubMed ID: 2163042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels.
    Ramoa AS; Alkondon M; Aracava Y; Irons J; Lunt GG; Deshpande SS; Wonnacott S; Aronstam RS; Albuquerque EX
    J Pharmacol Exp Ther; 1990 Jul; 254(1):71-82. PubMed ID: 1694895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glycine regulation of the N-methyl-D-aspartate receptor-gated ion channel in hippocampal membranes.
    Bonhaus DW; Yeh GC; Skaryak L; McNamara JO
    Mol Pharmacol; 1989 Aug; 36(2):273-9. PubMed ID: 2475759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple sites for the regulation of the N-methyl-D-aspartate receptor.
    Reynolds IJ; Miller RJ
    Mol Pharmacol; 1988 Jun; 33(6):581-4. PubMed ID: 2837634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kinetic characterization of the phencyclidine-N-methyl-D-aspartate receptor interaction: evidence for a steric blockade of the channel.
    Kloog Y; Haring R; Sokolovsky M
    Biochemistry; 1988 Feb; 27(3):843-8. PubMed ID: 2835078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Binding properties of 3-[125I]iodophencyclidine, a new radioligand for N-methyl-D-aspartate-gated ionic channels.
    Chicheportiche R; Guiramand J; Kamenka JM; Ponchant M; Beaucourt JP
    J Neurochem; 1992 Aug; 59(2):492-9. PubMed ID: 1378488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [3H]MK-801 binding in Alzheimer's disease.
    Mouradian MM; Contreras PC; Monahan JB; Chase TN
    Neurosci Lett; 1988 Nov; 93(2-3):225-30. PubMed ID: 2853845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.